A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK)

PURPOSE: Approval of eribulin for metastatic breast cancer was based on data primarily from Western patients, and there is a paucity of data on the effectiveness and safety of eribulin for Asian patients. To determine the effectiveness and safety of eribulin in Korean women with breast cancer in a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Min Ho, Lee, Soo Jung, Noh, Woo Chul, Jeon, Chang Wan, Lee, Seok Won, Son, Gil Soo, Moon, Byung-In, Lee, Jin Sun, Kang, Sung Soo, Suh, Young Jin, Gwak, Geumhee, Kim, Tae Hyun, Yoo, Young Bum, Kim, Hyun-Ah, Kim, Min Young, Kim, Ju Yeon, Jeong, Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519365/
https://www.ncbi.nlm.nih.gov/pubmed/32980648
http://dx.doi.org/10.1016/j.breast.2020.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519365/
https://www.ncbi.nlm.nih.gov/pubmed/32980648
http://dx.doi.org/10.1016/j.breast.2020.09.004

Ejemplares similares